CD36 Lentiviral Vector (human)
To Order Contact us: bjorn@lembcke.dk
CD36 |
|||
36PE-100T | ImmunoStep | 100 test | EUR 559.2 |
CD36 |
|||
36PP5.52-100T | ImmunoStep | 100 test | EUR 590.4 |
CD36 |
|||
36PU2-01MG | ImmunoStep | 100 test | EUR 450 |
CD36 |
|||
PR27320 | Neuromics | 5 ug | EUR 381.6 |
CD36 |
|||
RA25035 | Neuromics | 100 ul | EUR 506.4 |
Cd36/ Rat Cd36 ELISA Kit |
|||
ELI-02353r | Lifescience Market | 96 Tests | EUR 1063.2 |
CD36 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
LV675289 | ABM | 1.0 ug DNA | EUR 818.4 |
CD36 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
LV675293 | ABM | 1.0 ug DNA | EUR 818.4 |
CD36 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
LV675294 | ABM | 1.0 ug DNA | EUR 818.4 |
CD36 Antibody |
|||
1-CSB-PA09479A0Rb | Cusabio |
|
|
Description: A polyclonal antibody against CD36. Recognizes CD36 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200 |
CD36 Antibody |
|||
1-CSB-PA004927GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against CD36. Recognizes CD36 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC |
CD36 Antibody |
|||
DF13262 | Affbiotech | 100ul | EUR 420 |
CD36 siRNA |
|||
20-abx911015 | Abbexa |
|
|
CD36 siRNA |
|||
20-abx911016 | Abbexa |
|
|
CD36 Antibody |
|||
1-CSB-PA006183 | Cusabio |
|
|
Description: A polyclonal antibody against CD36. Recognizes CD36 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000 |
CD36 Antibody |
|||
1-CSB-PA569109 | Cusabio |
|
|
Description: A polyclonal antibody against CD36. Recognizes CD36 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:50-1:200 |
CD36 Antibody |
|||
1-CSB-PA616030 | Cusabio |
|
|
Description: A polyclonal antibody against CD36. Recognizes CD36 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:50-1:200 |
CD36 antibody |
|||
70R-6098 | Fitzgerald | 50 ug | EUR 560.4 |
Description: Rabbit polyclonal CD36 antibody |
CD36 antibody |
|||
70R-6104 | Fitzgerald | 50 ug | EUR 560.4 |
Description: Rabbit polyclonal CD36 antibody |
CD36 Antibody |
|||
49232-100ul | SAB | 100ul | EUR 399.6 |
CD36 Antibody |
|||
49232-50ul | SAB | 50ul | EUR 286.8 |
CD36 antibody |
|||
70R-16271 | Fitzgerald | 50 ul | EUR 522 |
Description: Rabbit polyclonal CD36 antibody |
CD36 antibody |
|||
10R-6387 | Fitzgerald | 100 ug | EUR 249.6 |
Description: Rat monoclonal CD36 antibody |
CD36 antibody |
|||
10R-6388 | Fitzgerald | 100 ug | EUR 327.6 |
Description: Mouse monoclonal CD36 antibody |
CD36 antibody |
|||
10R-CD36aHU | Fitzgerald | 200 tests | EUR 502.8 |
Description: Mouse monoclonal CD36 antibody |
CD36 Antibody |
|||
33046-100ul | SAB | 100ul | EUR 302.4 |
CD36 antibody |
|||
10R-3612 | Fitzgerald | 100 ul | EUR 829.2 |
Description: Mouse monoclonal CD36 antibody |
CD36 antibody |
|||
10-2582 | Fitzgerald | 100 ug | EUR 289.2 |
Description: Mouse monoclonal CD36 antibody |
CD36 protein |
|||
80R-4357 | Fitzgerald | 20 ug | EUR 418.8 |
Description: Purified Recombinant CD36 protein (His tagged) |
CD36 Antibody |
|||
F48293-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
CD36 Antibody |
|||
F48293-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
CD36 Antibody |
|||
R31985 | NSJ Bioreagents | 100 ug | EUR 419 |
CD36 Antibody |
|||
V3002-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: CD36 binds to collagen, thrombospondin, anionic phospholipids and oxidized low-density lipoprotein (oxLDL). May function as a cell adhesion molecule. Directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Receptor for thombospondins, THBS1 AND THBS2, mediating their antiangiogenic effects. As a coreceptor for TLR4-TLR6 heterodimer, promotes inflammation in monocytes/macrophages. Upon ligand binding, such as oxLDL or amyloid-beta 42, rapidly induces the formation of a heterodimer of TLR4 and TLR6, which is internalized and triggers inflammatory response, leading to NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion. [UniProt] |
CD36 Antibody |
|||
V3002-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: CD36 binds to collagen, thrombospondin, anionic phospholipids and oxidized low-density lipoprotein (oxLDL). May function as a cell adhesion molecule. Directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Receptor for thombospondins, THBS1 AND THBS2, mediating their antiangiogenic effects. As a coreceptor for TLR4-TLR6 heterodimer, promotes inflammation in monocytes/macrophages. Upon ligand binding, such as oxLDL or amyloid-beta 42, rapidly induces the formation of a heterodimer of TLR4 and TLR6, which is internalized and triggers inflammatory response, leading to NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion. [UniProt] |
CD36 Antibody |
|||
V3002SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: CD36 binds to collagen, thrombospondin, anionic phospholipids and oxidized low-density lipoprotein (oxLDL). May function as a cell adhesion molecule. Directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Receptor for thombospondins, THBS1 AND THBS2, mediating their antiangiogenic effects. As a coreceptor for TLR4-TLR6 heterodimer, promotes inflammation in monocytes/macrophages. Upon ligand binding, such as oxLDL or amyloid-beta 42, rapidly induces the formation of a heterodimer of TLR4 and TLR6, which is internalized and triggers inflammatory response, leading to NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion. [UniProt] |
CD36 Antibody |
|||
V3003-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 80kDa-90kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36. |
CD36 Antibody |
|||
V3003-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Recognizes a protein of 80kDa-90kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36. |
CD36 Antibody |
|||
V3003SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 80kDa-90kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36. |
CD36 Antibody |
|||
V3004-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 80kDa-90kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36. |
CD36 Antibody |
|||
V3004-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Recognizes a protein of 80kDa-90kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36. |
CD36 Antibody |
|||
V3004SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 80kDa-90kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36. |
CD36 Antibody |
|||
V3005-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 80kDa-90kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36. |
CD36 Antibody |
|||
V3005-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
Description: Recognizes a protein of 80kDa-90kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36. |
CD36 Antibody |
|||
V3005SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
Description: Recognizes a protein of 80kDa-90kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36. |
CD36 Antibody |
|||
V8886-100UG | NSJ Bioreagents | 100ug | EUR 499 |
Description: Recognizes a protein of 80kDa-90kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36. |
CD36 Antibody |
|||
V8886-20UG | NSJ Bioreagents | 20ug | EUR 219 |
Description: Recognizes a protein of 80kDa-90kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36. |
CD36 Antibody |
|||
V8886SAF-100UG | NSJ Bioreagents | 100ug | EUR 499 |
Description: Recognizes a protein of 80kDa-90kDa, identified as CD36. It is expressed on platelets, monocytes and macrophages, microvascular endothelial cells, erythrocyte precursors, mammary epithelial cells, and some macrophage derived dendritic cells. CD36 acts as a receptor for thrombospondin (TSP), collagen types I, IV and V, P. falciparum malaria-infected erythrocytes, and sickle erythrocytes. It also functions as a scavenger receptor, mediating macrophage uptake of oxidized low-density lipoprotein (LDL) and recognition of apoptotic polymorphonuclear leukocytes (PMN). CD36 plays a role in platelet aggregation, macrophage foam cell development, inflammation, and the tissue ischemia observed in sickle cell disease and cerebral malaria. Note that 1-4% of Japanese and East Asia population lack CD36. |
Human CD36 shRNA Plasmid |
|||
20-abx950670 | Abbexa |
|
|
Human CD36 ELISA Kit |
|||
ELA-E0674h | Lifescience Market | 96 Tests | EUR 988.8 |
CD36 Recombinant Protein (Human) |
|||
RP006346 | ABM | 100 ug | Ask for price |
Cd36 ORF Vector (Rat) (pORF) |
|||
ORF064649 | ABM | 1.0 ug DNA | EUR 607.2 |
Cd36 ORF Vector (Mouse) (pORF) |
|||
ORF040854 | ABM | 1.0 ug DNA | EUR 607.2 |
Cd36 ORF Vector (Mouse) (pORF) |
|||
ORF040855 | ABM | 1.0 ug DNA | EUR 607.2 |
Cd36 ORF Vector (Mouse) (pORF) |
|||
ORF040856 | ABM | 1.0 ug DNA | EUR 607.2 |
Cd36 ORF Vector (Mouse) (pORF) |
|||
ORF040857 | ABM | 1.0 ug DNA | EUR 607.2 |
Cd36 ORF Vector (Mouse) (pORF) |
|||
ORF040858 | ABM | 1.0 ug DNA | EUR 607.2 |
CD36 Protein Vector (Human) (pPB-C-His) |
|||
PV008461 | ABM | 500 ng | EUR 394.8 |
CD36 Protein Vector (Human) (pPB-N-His) |
|||
PV008462 | ABM | 500 ng | EUR 394.8 |
CD36 Protein Vector (Human) (pPM-C-HA) |
|||
PV008463 | ABM | 500 ng | EUR 394.8 |
CD36 Protein Vector (Human) (pPM-C-His) |
|||
PV008464 | ABM | 500 ng | EUR 394.8 |
Human CellExp? CD36, human recombinant |
|||
7371-10 | Biovision | EUR 294 |
Human CellExp? CD36, human recombinant |
|||
7371-50 | Biovision | EUR 836.4 |
Human Soluble CD36 ELISA kit |
|||
E01S0230-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Human Soluble CD36 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Soluble CD36 ELISA kit |
|||
E01S0230-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
Description: A competitive ELISA for quantitative measurement of Human Soluble CD36 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Soluble CD36 ELISA kit |
|||
E01S0230-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
Description: A competitive ELISA for quantitative measurement of Human Soluble CD36 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
CD36 ELISA Kit (Human) (OKAN05010) |
|||
OKAN05010 | Aviva Systems Biology | 96 Wells | EUR 950.4 |
Description: Description of target: The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.056 ng/mL |
CD36 ELISA Kit (Human) (OKCD07472) |
|||
OKCD07472 | Aviva Systems Biology | 96 Wells | EUR 1123.2 |
Description: Description of target: CD36 is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in its gene cause platelet glycoprotein deficiency. The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.056ng/mL |
CD36(1E8.) Antibody |
|||
BNCA0314-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CD36(1E8.), APC conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNCAP0314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNCAP0314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD36 Polyclonal Antibody |
|||
ABP53316-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of CD36 from Human, Mouse, Rat. This CD36 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD36 |
CD36 Polyclonal Antibody |
|||
ABP53316-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of CD36 from Human, Mouse, Rat. This CD36 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD36 |
CD36 Polyclonal Antibody |
|||
ABP53316-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of CD36 from Human, Mouse, Rat. This CD36 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD36 |
CD36 Rabbit pAb |
|||
A5792-100ul | Abclonal | 100 ul | EUR 369.6 |
CD36 Rabbit pAb |
|||
A5792-200ul | Abclonal | 200 ul | EUR 550.8 |
CD36 Rabbit pAb |
|||
A5792-20ul | Abclonal | 20 ul | EUR 219.6 |
CD36 Rabbit pAb |
|||
A5792-50ul | Abclonal | 50 ul | EUR 267.6 |
CD36(1E8.) Antibody |
|||
BNC610314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), CF660R conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC610314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), CF660R conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC680314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), CF568 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC680314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), CF568 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNCR0314-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CD36(1E8.), RPE conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNUB0314-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against CD36(1E8.), Concentration: 0.2mg/mL |
CD36(1E8.) Antibody |
|||
BNUB0314-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against CD36(1E8.), Concentration: 0.2mg/mL |
CD36(1E8.) Antibody |
|||
BNC430314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), CF543 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC430314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), CF543 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC470314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), CF647 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC470314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), CF647 conjugate, Concentration: 0.1mg/mL |
CD36 Conjugated Antibody |
|||
C49232 | SAB | 100ul | EUR 476.4 |
CD36(1E8.) Antibody |
|||
BNC400314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), CF640R conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC400314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), CF640R conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC880314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), CF488A conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC880314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), CF488A conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC810314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), CF680R conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC810314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), CF680R conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNCP0314-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against CD36(1E8.), PerCP conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNUM0314-50 | Biotium | 50uL | EUR 474 |
Description: Primary antibody against CD36(1E8.), 1mg/mL |
CD36(1E8.) Antibody |
|||
BNC050314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), CF405M conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC050314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), CF405M conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC700314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), CF770 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC700314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), CF770 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC800314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), CF680 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC800314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), CF680 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNCB0314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), Biotin conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNCB0314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), Biotin conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC940314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), CF594 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC940314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), CF594 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC550314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), CF555 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNC550314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), CF555 conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNCH0314-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against CD36(1E8.), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD36(1E8.) Antibody |
|||
BNCH0314-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against CD36(1E8.), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD36 cloning plasmid |
|||
CSB-CL004927HU-10ug | Cusabio | 10ug | EUR 608.4 |
Description: A cloning plasmid for the CD36 gene. |
anti- CD36 antibody |
|||
FNab01470 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against CD36 |
CD36 Polyclonal Antibody |
|||
ES4315-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against CD36 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
CD36 Polyclonal Antibody |
|||
ES4315-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against CD36 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
CD36 antibody (PE) |
|||
61R-1239 | Fitzgerald | 100 ug | EUR 424.8 |
Description: Rat monoclonal CD36 antibody (PE) |
CD36 antibody (FITC) |
|||
61R-CD36aHU | Fitzgerald | 100 tests | EUR 571.2 |
Description: Mouse monoclonal CD36 antibody (FITC) |
CD36 Rabbit pAb |
|||
A1470-100ul | Abclonal | 100 ul | EUR 369.6 |
CD36 Rabbit pAb |
|||
A1470-200ul | Abclonal | 200 ul | EUR 550.8 |
CD36 Rabbit pAb |
|||
A1470-20ul | Abclonal | 20 ul | EUR 219.6 |
CD36 Rabbit pAb |
|||
A1470-50ul | Abclonal | 50 ul | EUR 267.6 |
CD36 Rabbit pAb |
|||
A14714-100ul | Abclonal | 100 ul | EUR 369.6 |
CD36 Rabbit pAb |
|||
A14714-200ul | Abclonal | 200 ul | EUR 550.8 |
CD36 Rabbit pAb |
|||
A14714-20ul | Abclonal | 20 ul | EUR 219.6 |
CD36 Rabbit pAb |
|||
A14714-50ul | Abclonal | 50 ul | EUR 267.6 |
CD36 Blocking Peptide |
|||
33R-4679 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CD36 antibody, catalog no. 70R-6098 |